{
    "nct_id": "NCT03104114",
    "official_title": "Evaluating Adherence and Persistence in Patients Receiving Oral Oncolytic Therapy in a Safety Net Hospital's Pharmacist-driven Medication Management Program",
    "inclusion_criteria": "1. Treatment with 1 or more oral oncology agents. Oral oncology agent defined as medication taken mouth with the purpose to treat a patient's cancer\n2. Treatment dispensed through the BMC Specialty Pharmacy\n3. Age>18 years\n4. Life expectancy >6 months\n5. Patients must have ability to give written consent, or, must have a legally authorized representative\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Treatment indicated for neoadjuvant, adjuvant, peri-operative treatment\n2. Concurrent radiation treatment\n3. Patients that are unable to have oral oncology agents dispense through BMC Specialty Pharmacy\n\nHistorical Control:\n\n1. 2 controls:1 intervention match\n2. Matched to a patient in intervention group based on drug type",
    "miscellaneous_criteria": "Pharmacist-intervention group"
}